New Delhi, April 09, 2021
The Philippines on Thursday temporarily suspended the use of the AstraZeneca vaccine against Covid-19 for those younger than 60 years of age following reports of rare blood clots in some recipients.
The country’s Food and Drug Administration called the suspension “a precautionary measure to ensure the safety of every Filipino”.
Several European countries and Canada have also put age restrictions in place due to a handful of blood clot cases reported in younger people.
The Philippines has received an initial shipment of 525,600 doses of the AstraZeneca vaccine through the WHO Covax facility.